Harmony Biosciences
HRMY
HRMY
270 hedge funds and large institutions have $1.67B invested in Harmony Biosciences in 2025 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 100 increasing their positions, 87 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4.94% less ownership
Funds ownership: 92.5% → 87.56% (-4.9%)
8% less capital invested
Capital invested by funds: $1.82B → $1.67B (-$150M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
270
Holding in Top 10
3
Calls
$4.95M
Puts
$1.57M
Top Buyers
| 1 | +$17M | |
| 2 | +$9.74M | |
| 3 | +$8.92M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$8.56M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$7.47M |
Top Sellers
| 1 | -$63.9M | |
| 2 | -$49.9M | |
| 3 | -$18.1M | |
| 4 |
BlackRock
New York
|
-$16.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.9M |